Patents by Inventor Sook Kyung PARK

Sook Kyung PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240144270
    Abstract: A vehicle-to-everything (V2X) communication-based electronic toll collection system (ETCS) according to an embodiment of the present invention includes at least one roadside unit (RSU), a token issuer checking a de-identified token of a vehicle by communicating with an on-board unit (OBU) of the vehicle via the at least one roadside unit, and a clearing house communicating with the token issuer and charging a toll to a driver/owner of the vehicle. The token issuer generates toll information of the vehicle based on the de-identified token of the vehicle and location information of the at least one roadside unit involved in checking the de-identified token.
    Type: Application
    Filed: November 28, 2022
    Publication date: May 2, 2024
    Inventors: Duk Soo KIM, Eui Seok KIM, Sang Gyoo SIM, Ki Ho JOO, Jung Won LEE, Jong Guk LEE, Jung Wook KIM, Sang Seok LEE, Sang Min LEE, Sook Jun GWEON, Hyun Kyung PARK
  • Publication number: 20240051951
    Abstract: The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present invention can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
    Type: Application
    Filed: June 8, 2023
    Publication date: February 15, 2024
    Inventors: Yong Je SHIN, Jin Hee KIM, Jun LEE, Sook Kyung PARK, Ho Yeon LEE, Hyun Suk CHOI, Se Hyuk KIM, Eun Ji KANG, Ho Youl LEE, Soo Yeon JUNG
  • Publication number: 20230286965
    Abstract: The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present disclosure can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
    Type: Application
    Filed: March 17, 2023
    Publication date: September 14, 2023
    Inventors: Yong Je SHIN, Jin Hee KIM, Jun LEE, Sook Kyung PARK, Ho Yeon LEE, Hyun Suk CHOI, Se Hyuk KIM, Eun Ji KANG, Ho Youl LEE, Soo Yeon JUNG
  • Patent number: 11725001
    Abstract: The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present invention can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
    Type: Grant
    Filed: July 19, 2021
    Date of Patent: August 15, 2023
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Yong Je Shin, Jin Hee Kim, Jun Lee, Sook Kyung Park, Ho Yeon Lee, Hyun Suk Choi, Se Hyuk Kim, Eun Ji Kang, Ho Youl Lee, Soo Yeon Jung
  • Publication number: 20230023140
    Abstract: The present invention relates to a 6-6 bicyclic ring-containing compound derivative and use thereof. The compound according to the present invention acts as a PRMT5 inhibitor, and thus can be effectively used in the prevention or treatment of diseases caused by PRMT5.
    Type: Application
    Filed: October 22, 2020
    Publication date: January 26, 2023
    Inventors: Yong Je SHIN, Jin Hee KIM, Jun LEE, Hyun Suk CHOI, Se Hyuk KIM, Eun Ji KANG, Sook Kyung PARK, Ho Youl LEE, Ho Yeon LEE
  • Publication number: 20220402902
    Abstract: The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present invention can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
    Type: Application
    Filed: July 19, 2021
    Publication date: December 22, 2022
    Inventors: Yong Je SHIN, Jin Hee KIM, Jun LEE, Sook Kyung PARK, Ho Yeon LEE, Hyun Suk CHOI, Se Hyuk KIM, Eun Ji KANG, Ho Youl LEE, Soo Yeon JUNG
  • Patent number: 11111237
    Abstract: The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present invention can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: September 7, 2021
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Yong Je Shin, Jin Hee Kim, Jun Lee, Sook Kyung Park, Ho Yeon Lee, Hyun Suk Choi, Se Hyuk Kim, Eun Ji Kang, Ho Youl Lee, Soo Yeon Jung
  • Publication number: 20210101892
    Abstract: The present disclosure relates to a compound derivative containing a 6-7 bicyclic ring and use thereof. The compound according to the present invention can be effectively used in the prevention or treatment of diseases caused by PRMT5 by acting as a PRMT5 inhibitor.
    Type: Application
    Filed: November 24, 2020
    Publication date: April 8, 2021
    Inventors: Yong Je SHIN, Jin Hee KIM, Jun LEE, Sook Kyung PARK, Ho Yeon LEE, Hyun Suk CHOI, Se Hyuk KIM, Eun Ji KANG, Ho Youl LEE, Soo Yeon JUNG
  • Patent number: 10047041
    Abstract: The present invention relates to a novel amino-phenyl-sulfonyl-acetate derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating diabetes comprising the same as an active ingredient.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: August 14, 2018
    Assignee: CJ HEALTHCARE CORPORATION
    Inventors: Jae Ho Yoo, Seung Chan Kim, Soo Yeon Jung, Hyoung Rok Bak, Young Mee Chung, Sung Jun Kim, Sook Kyung Park, Seog Beom Song, Shin-Young Ryu, Mi Young Yoon, Dong Hyun Ko, Sun Young Park, Chi Hye Park, Nak Hyun Choi
  • Patent number: 9815840
    Abstract: The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.
    Type: Grant
    Filed: August 29, 2014
    Date of Patent: November 14, 2017
    Assignee: The Asan Foundation
    Inventors: Tae Gon Baik, Won-Hyuk Jung, Seung In Kim, Seung Chan Kim, Sook Kyung Park, Su Yeon Jung, Seung Hee Ji, So Young Ki, Min Cheol Kim, Eun Young Lee, Eun Mi Hong
  • Publication number: 20170247320
    Abstract: The present invention relates to a novel amino-phenyl-sulfonyl-acetate derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating diabetes comprising the same as an active ingredient.
    Type: Application
    Filed: July 14, 2015
    Publication date: August 31, 2017
    Applicant: CJ Healthcare Corporation
    Inventors: Jae Ho Yoo, Seung Chan Kim, Soo Yeon Jung, Hyoung Rok Bak, Young Mee Chung, Sung Jun Kim, Sook Kyung Park, Seog Beom Song, Shin-Young Ryu, Mi Young Yoon, Dong Hyun Ko, Sun Young Park, Chi Hye Park, Nak Hyun Choi
  • Publication number: 20160207931
    Abstract: The present invention relates to a pyrrolopyridazine derivative represented by Formula 1 of the detailed description, or a pharmaceutically acceptable salt thereof. The compound according to the present invention and a pharmaceutically acceptable salt thereof can inhibit the activity of protein kinase(s), and thus are useful for preventing or treating diseases related thereto.
    Type: Application
    Filed: August 29, 2014
    Publication date: July 21, 2016
    Applicant: CJ Healthcare Corporation
    Inventors: Tae Gon BAIK, Won-Hyuk JUNG, Seung In KIM, Seung Chan KIM, Sook Kyung PARK, Su Yeon JUNG, Seung Hee JI, So Young KI, Min Cheol KIM, Eun Young LEE, Eun Mi HONG